Table 1.
Demographic, pathological and clinical characteristics of the study cohort (N = 2 047).
| Characteristic | n (%) |
|---|---|
| Age | |
| <60 years | 540 (26.4) |
| 60–69 years | 693 (33.9) |
| 70–79 years | 635 (31.0) |
| ≥80 years | 179 (8.7) |
| Gender | |
| Male | 1 621 (79.2) |
| Female | 426 (20.8) |
| Pathological stage | |
| pT0 | 152 (7.4) |
| pTa/pTis | 326 (15.9) |
| pT1 | 358 (17.5) |
| pT2A | 205 (10.0) |
| pT2B | 256 (12.5) |
| pT3A | 189 (9.2) |
| pT3B | 352 (17.2) |
| pT4A | 190 (9.3) |
| pT4B | 19 (0.9) |
| Pathological grade | |
| Low | 330 (16.1) |
| High | 1 717 (83.9) |
| CIS | |
| Absent | 1 480 (72.3) |
| Present | 567 (27.7) |
| Prostatic pathology | |
| None | 1 345 (65.7) |
| Urethral or Ductal UC | 113 (5.5) |
| Stromal UC | 163 (8.0) |
| Female | 426 (20.8) |
| Urethrectomy | 145 (0.07) |
| Diversion type | |
| Ileal conduit | 418 (20.4) |
| Neobladder | 1 245 (61.3) |
| Continent catheterizable stoma | 375 (18.3) |
| Chemotherapy | |
| Neoadjuvant | 132 (6.5) |
| Adjuvant | 427 (20.9) |
| Preoperative radiation | 140 (6.8) |
CIS, carcinoma in situ.